| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |